Glycifon ointment for basal cell carcinoma: treatment experience

Cover Page

Cite item

Full Text

Abstract

It has been held studying of the remote results of treatment of 80 patients sick of a bazalioma by 30 % glyciphon ointment in the Republican Oncologic Dispensary of the Ministry of Health of Republic of Tatarstan. It is established that daily use of glyciphon ointment during the 20– 30 days cures patients with primary tumours, both single, and initially-plural I and II stages, in 98,3 % cases. The preparation is effective at recidivations of bazalioma arising after radiotherapy, surgical treatment, criotherapy. The using at recidivations after the combined treatment is inexpedient. Reduction of an exposition of ointment from 24 hours till 6 hours gives good clinical effect with absence of relapses of recidivations of tumors.

About the authors

R. S. Garaev

Kazan’ State Medical University at the Ministry of Health of Russia

Author for correspondence.
Email: garaevrs@mail.ru
49 Butlerova St., Kazan’, 420012 Russian Federation

L. N. Zalyalutdinova

Kazan’ State Medical University at the Ministry of Health of Russia

49 Butlerova St., Kazan’, 420012 Russian Federation

V. R. Gil’mutdinova

Kazan’ State Medical University at the Ministry of Health of Russia

49 Butlerova St., Kazan’, 420012 Russian Federation

R. Sh. Khasanov

Kazan’ State Medical Academy at the Ministry of Health of Russia

11 Mushtari St., Kazan’, 420012 Russian Federation

References

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2016 Garaev R.S., Zalyalutdinova L.N., Gil’mutdinova V.R., Khasanov R.S.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77-36990 от  21.07.2009.